Randomized Controlled Clinical Trial To Study Efficacy Of Hinstradi Kwath With Patoladi Kwath In The Management Of Urdhwag Amlapitta
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Assessment will be done based on subjective criteria.
研究概览
简要总结
Topic:-"RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY EFFICACY OF HINSTRADI KWATH WITH PATOLADI KWATH IN THE MANAGEMENT OF URDHWAG AMLAPITTA"
Objectives
Primary Objectives:-To evaluate the efficacy of Hinstradi Kwath in the management of Urdhwag Amlapitta.
Secondary Objectives:-1.To compare the effect of Hinstradi Kwath and Patoladi Kwath in the management of Urdhwag Amlapitta.
Methodology :- Study design
Screening of patients for inclusion
Selection of patients on basis of Inclusion Criteria and Exclusion Criteria.
Consent taken Grouping of Patients
Trial will be conducted in our institute. Total 60 patients diagnosed with classical signs and symptoms of Urdhwag Amlapitta be selected and then will be divided in two groups.
Hinstradi Kwath will be given to one group and Patoladi Kwath will be given to another one.
The study will be conducted for 21 days. Result will be compared in two groups.
Data analysis will be done by using appropriate statistical test.
INCLUSION CRITERIA
1.Patients with clinical signs and symptoms of Urdhwag Amlapitta will be selected.
-
Patients of age group between 20-50 years.
-
Patients will be selected irrespective of age, Sex, socio economic status.
Exclusion Criteria:-
1.Those patients who are not willing to give consent.
- Patient will be excluded below age 20 years and above 50 years old.
3Patient suffering from any infectious disease like bacterial or viral.
4.Pregnant and lactating women.
Withdrawal Criteria :-
-
Patients who refuse to treatment.
-
Patients with irregular follow up.
3.If any complication or adverse effect found during period of treatment.
4.If symptoms aggravated during treatment will be withdrawn.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients with clinical signs and symptoms of Urdhwag Amlapitta will be selected.
- •Patients of age group between 20-50 years.
- •Patients will be selected irrespective of age, Sex, socio economic status.
排除标准
- •1.Those patients who are not willing to give consent.
- •Patient will be excluded below age 20 years and above 50 years old.
- •3 Patient suffering from any infectious disease like bacterial or viral.
- •Pregnant and lactating women.
结局指标
主要结局
Assessment will be done based on subjective criteria.
时间窗: After 21 days
Subjective criteria is Avipak,Utklesha,Tikta Amla Udgara, Aruchi,Shirorujah,Gaurav
时间窗: After 21 days
will be assessed based on before and after treatment.
时间窗: After 21 days
次要结局
未报告次要终点
研究者
Vd Shejal Bhujangrao Inkar
Vidarbha Ayurved Mahavidyalaya, Amravati